Lack of mitochondrial DNA deletions in lesions of multiple sclerosis

Andrei Blokhin, Tamara Vyshkina, S. Komoly, B. Kálmán

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To test if mitochondrial (mt)DNA deletions accumulate in brains of patients with multiple sclerosis (MS). Background: Previous studies demonstrated an accumulation of oxidative damage to mtDNA and decreased activity of mitochondrial enzymes in lesions of MS, where activated immune cells produce increased amounts of reactive oxygen species and nitric oxide. The unknown link between oxidative damage and decreased activity of mitochondrial enzymes may be the accumulation of deletions in mtDNA molecules. mtDNA deletions in the brain have been associated with neurodegeneration and aging. Methods: mtDNA deletions were quantified by using real-time PCR in laser-dissected, COX-positive and COX-negative single neuronal and glial cells from frozen postmortem brain tissue specimens including normal appearing gray (NAGM) and white matter (NAWM) regions and chronic active plaques of MS patients, and gray matter (GM) and white matter (WM) regions of age-matched controls. Three patients with advance Alzheimer's and Parkinson's diseases were included as positive controls. The proportion of deleted mtDNA molecules was correlated with pathology and age. Results: We detected no pathology-related accumulation of mtDNA deletions when comparisons were made among NAGM, NAWM, and plaque of MS brains, or between NAGM-GM and NAWM-WM of patients and age-matched controls. However, an accumulation of mtDNA deletions was noted in non-neurological controls beyond 60 years of age and in patients with Alzheimer's and Parkinson's diseases. As expected, the rate of mtDNA deletions was higher in COX- than in COX+ cells. Conclusion: While aging and neurodegeneration in PD and AD are associated with accumulation of COX- cells and mtDNA deletions, the pathology of MS is not.

Original languageEnglish
Pages (from-to)187-194
Number of pages8
JournalNeuroMolecular Medicine
Volume10
Issue number3
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Mitochondrial DNA
Multiple Sclerosis
Brain
Pathology
Parkinson Disease
Alzheimer Disease
Enzymes
Neuroglia
Real-Time Polymerase Chain Reaction
Reactive Oxygen Species
Nitric Oxide
Lasers
White Matter

Keywords

  • Acquired mitochondrial abnormalities
  • Aging
  • Mitochondrial DNA deletions
  • Multiple sclerosis
  • Neurodegeneration

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Molecular Medicine
  • Neurology

Cite this

Lack of mitochondrial DNA deletions in lesions of multiple sclerosis. / Blokhin, Andrei; Vyshkina, Tamara; Komoly, S.; Kálmán, B.

In: NeuroMolecular Medicine, Vol. 10, No. 3, 09.2008, p. 187-194.

Research output: Contribution to journalArticle

Blokhin, Andrei ; Vyshkina, Tamara ; Komoly, S. ; Kálmán, B. / Lack of mitochondrial DNA deletions in lesions of multiple sclerosis. In: NeuroMolecular Medicine. 2008 ; Vol. 10, No. 3. pp. 187-194.
@article{50e0307c1360462eb7775c702673e8a4,
title = "Lack of mitochondrial DNA deletions in lesions of multiple sclerosis",
abstract = "Objective: To test if mitochondrial (mt)DNA deletions accumulate in brains of patients with multiple sclerosis (MS). Background: Previous studies demonstrated an accumulation of oxidative damage to mtDNA and decreased activity of mitochondrial enzymes in lesions of MS, where activated immune cells produce increased amounts of reactive oxygen species and nitric oxide. The unknown link between oxidative damage and decreased activity of mitochondrial enzymes may be the accumulation of deletions in mtDNA molecules. mtDNA deletions in the brain have been associated with neurodegeneration and aging. Methods: mtDNA deletions were quantified by using real-time PCR in laser-dissected, COX-positive and COX-negative single neuronal and glial cells from frozen postmortem brain tissue specimens including normal appearing gray (NAGM) and white matter (NAWM) regions and chronic active plaques of MS patients, and gray matter (GM) and white matter (WM) regions of age-matched controls. Three patients with advance Alzheimer's and Parkinson's diseases were included as positive controls. The proportion of deleted mtDNA molecules was correlated with pathology and age. Results: We detected no pathology-related accumulation of mtDNA deletions when comparisons were made among NAGM, NAWM, and plaque of MS brains, or between NAGM-GM and NAWM-WM of patients and age-matched controls. However, an accumulation of mtDNA deletions was noted in non-neurological controls beyond 60 years of age and in patients with Alzheimer's and Parkinson's diseases. As expected, the rate of mtDNA deletions was higher in COX- than in COX+ cells. Conclusion: While aging and neurodegeneration in PD and AD are associated with accumulation of COX- cells and mtDNA deletions, the pathology of MS is not.",
keywords = "Acquired mitochondrial abnormalities, Aging, Mitochondrial DNA deletions, Multiple sclerosis, Neurodegeneration",
author = "Andrei Blokhin and Tamara Vyshkina and S. Komoly and B. K{\'a}lm{\'a}n",
year = "2008",
month = "9",
doi = "10.1007/s12017-008-8025-2",
language = "English",
volume = "10",
pages = "187--194",
journal = "NeuroMolecular Medicine",
issn = "1535-1084",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Lack of mitochondrial DNA deletions in lesions of multiple sclerosis

AU - Blokhin, Andrei

AU - Vyshkina, Tamara

AU - Komoly, S.

AU - Kálmán, B.

PY - 2008/9

Y1 - 2008/9

N2 - Objective: To test if mitochondrial (mt)DNA deletions accumulate in brains of patients with multiple sclerosis (MS). Background: Previous studies demonstrated an accumulation of oxidative damage to mtDNA and decreased activity of mitochondrial enzymes in lesions of MS, where activated immune cells produce increased amounts of reactive oxygen species and nitric oxide. The unknown link between oxidative damage and decreased activity of mitochondrial enzymes may be the accumulation of deletions in mtDNA molecules. mtDNA deletions in the brain have been associated with neurodegeneration and aging. Methods: mtDNA deletions were quantified by using real-time PCR in laser-dissected, COX-positive and COX-negative single neuronal and glial cells from frozen postmortem brain tissue specimens including normal appearing gray (NAGM) and white matter (NAWM) regions and chronic active plaques of MS patients, and gray matter (GM) and white matter (WM) regions of age-matched controls. Three patients with advance Alzheimer's and Parkinson's diseases were included as positive controls. The proportion of deleted mtDNA molecules was correlated with pathology and age. Results: We detected no pathology-related accumulation of mtDNA deletions when comparisons were made among NAGM, NAWM, and plaque of MS brains, or between NAGM-GM and NAWM-WM of patients and age-matched controls. However, an accumulation of mtDNA deletions was noted in non-neurological controls beyond 60 years of age and in patients with Alzheimer's and Parkinson's diseases. As expected, the rate of mtDNA deletions was higher in COX- than in COX+ cells. Conclusion: While aging and neurodegeneration in PD and AD are associated with accumulation of COX- cells and mtDNA deletions, the pathology of MS is not.

AB - Objective: To test if mitochondrial (mt)DNA deletions accumulate in brains of patients with multiple sclerosis (MS). Background: Previous studies demonstrated an accumulation of oxidative damage to mtDNA and decreased activity of mitochondrial enzymes in lesions of MS, where activated immune cells produce increased amounts of reactive oxygen species and nitric oxide. The unknown link between oxidative damage and decreased activity of mitochondrial enzymes may be the accumulation of deletions in mtDNA molecules. mtDNA deletions in the brain have been associated with neurodegeneration and aging. Methods: mtDNA deletions were quantified by using real-time PCR in laser-dissected, COX-positive and COX-negative single neuronal and glial cells from frozen postmortem brain tissue specimens including normal appearing gray (NAGM) and white matter (NAWM) regions and chronic active plaques of MS patients, and gray matter (GM) and white matter (WM) regions of age-matched controls. Three patients with advance Alzheimer's and Parkinson's diseases were included as positive controls. The proportion of deleted mtDNA molecules was correlated with pathology and age. Results: We detected no pathology-related accumulation of mtDNA deletions when comparisons were made among NAGM, NAWM, and plaque of MS brains, or between NAGM-GM and NAWM-WM of patients and age-matched controls. However, an accumulation of mtDNA deletions was noted in non-neurological controls beyond 60 years of age and in patients with Alzheimer's and Parkinson's diseases. As expected, the rate of mtDNA deletions was higher in COX- than in COX+ cells. Conclusion: While aging and neurodegeneration in PD and AD are associated with accumulation of COX- cells and mtDNA deletions, the pathology of MS is not.

KW - Acquired mitochondrial abnormalities

KW - Aging

KW - Mitochondrial DNA deletions

KW - Multiple sclerosis

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=48749089524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749089524&partnerID=8YFLogxK

U2 - 10.1007/s12017-008-8025-2

DO - 10.1007/s12017-008-8025-2

M3 - Article

VL - 10

SP - 187

EP - 194

JO - NeuroMolecular Medicine

JF - NeuroMolecular Medicine

SN - 1535-1084

IS - 3

ER -